AVITA Medical Inc
AVITA Medical Inc (RCEL) Wheel Strategy
RCEL wheel strategy scan found 3 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 49.2%.
Read more
Running a RCEL wheel strategy lets you generate consistent premium income on AVITA Medical Inc while setting your own entry and exit prices on the underlying. AVITA Medical Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own RCEL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best RCEL wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on RCEL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable RCEL wheel from a losing one.
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older.
The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the RCEL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your RCEL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 10.00 | $0.05 | $0.85 | -0.31 | 63 | 18% | 53.2% | 49.2% | 1 |
| Oct 16, 2026 | 10.00 | $0.15 | $0.38 | -0.27 | 28 | 18% | 60.6% | 48.9% | 33 |
| Apr 16, 2027 | 7.50 | $0.05 | $1.18 | -0.18 | 210 | 18% | 59.1% | 27.2% | 1 |
As of September 18, 2026
Run the Wheel on RCEL With Confidence
Find the best RCEL wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→